Veraxa Biotech Holding AG Income Statement (2025) | VRXA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2025
Operating items
Selling, General & Administrative (Quarter)	11,080.36
Operating Expenses (Quarter)	11,080.36
Net income details
Profit After Tax (Quarter)	-33601.42

Veraxa Biotech Holding AG (VRXA)

NASDAQ: VRXA

$1.91 ▼ -0.10 (-4.98%)

Jul 28, 2026 · 12:30 PM UTC